Clinical Trials Directory

Trials / Completed

CompletedNCT06143605

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors

Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors Based on the Pathological Evaluation Following Initial Endoscopic Resection: A Multi-center Study

Status
Completed
Phase
Study type
Observational
Enrollment
527 (actual)
Sponsor
Yanhong Deng · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

we evaluated all related clinical and pathologic data of rectal NET cases, including the resection margin status, NET grading, and lymphovascular invasion status. Finally, the present study was aimed at (1) determining the risk factors for LN and distant metastases in colorectal NETs (2) clarifying the clinical significance of the salvage treatment for colorectal neuroendocrine tumors following initial endoscopic resection with positive resection margin status and (3) compare different salvage treatment of this uncommon disease through conducting a large, multi-center cohort study.

Conditions

Interventions

TypeNameDescription
PROCEDUREsalvage treatmentsalvage radical surgery or endoscopic resection

Timeline

Start date
2013-01-30
Primary completion
2022-12-30
Completion
2023-09-30
First posted
2023-11-22
Last updated
2023-11-22

Source: ClinicalTrials.gov record NCT06143605. Inclusion in this directory is not an endorsement.